Paper20175034
Current strategy for staging and treatment: the BCLC update and future prospects.
Forner A and 3 others. Semin Liver Dis, 2010. Cited by 891 papers, by iCite.
Cite this record
ConductScience Library. Current strategy for staging and treatment: the BCLC update and future prospects. Papers, record 20175034. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20175034
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Neoplasm Invasiveness | Major topic |
| Neoplasm Staging | Major topic |
| Antineoplastic Agents | |
| Benzenesulfonates | |
| Clinical Trials, Phase III as Topic | |
| Drug Delivery Systems | |
| Female | |
| Forecasting | |
| Hepatectomy | |
| Humans | |
| Liver Transplantation | |
| Male | |
| Niacinamide | |
| Phenylurea Compounds | |
| Prognosis | |
| Pyridines | |
| Randomized Controlled Trials as Topic | |
| Risk Assessment | |
| Sorafenib | |
| Spain | |
| Survival Analysis | |
| Treatment Outcome |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT03322280 | TACE Combined With Iodine-125 Seeds Implantation for HCC | Background | ClinicalTrials.gov | |
| NCT07657897 | The Impact of Anaesthesia and Sedation on Inflammation and NETosis in Hepatocellular Carcinoma Ablation | Results | ClinicalTrials.gov |
Cited by521
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 891 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42583674 | Decoding the Complexity of Hepatocellular Carcinoma: Clinical Challenges and Targeting HuR as a Novel Therapeutic Strategy. | Livers | 2026 | https://conductscience.org/library/papers/42583674 | PubMed |
| 42342274 | Trends in the incidence and surgical treatment of hepatocellular carcinoma in Ontario. | Can J Surg | 2026 | https://conductscience.org/library/papers/42342274 | PubMed |
| 42329540 | Advances in oncolytic viruses immunotherapy of hepatocellular carcinoma. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42329540 | PubMed |
| 42111212 | A BCLC-based prognostic nomogram for hepatocellular carcinoma: Development and validation. | iScience | 2026 | https://conductscience.org/library/papers/42111212 | PubMed |
| 41976373 | Modified Charlson Comorbidity Index to Improve Management of Patients with Hepatocellular Carcinoma: A Step Towards Multiparametric Approach. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41976373 | PubMed |
| 41602406 | Application of propensity score matching in prognostic analysis of portal hypertension in hepatocellular carcinoma patients. | Front Oncol | 2025 | https://conductscience.org/library/papers/41602406 | PubMed |
| 41374333 | Quantitative CT Perfusion and Radiomics Reveal Complementary Markers of Treatment Response in HCC Patients Undergoing TACE. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/41374333 | PubMed |
| 41166641 | Clinical management of liver cancer patients with immune checkpoint inhibitors treatment. | Hepat Oncol | 2025 | https://conductscience.org/library/papers/41166641 | PubMed |
| 41143168 | P-ART Score is a New Modification to Improve ART Score Predictive Accuracy for Patients with HCC Undergoing TACE. | J Hepatocell Carcinoma | 2025 | https://conductscience.org/library/papers/41143168 | PubMed |
| 41107444 | The efficacy and safety analysis of D-TACE combined with donafenib and tislelizumab in recurrent hepatocellular carcinoma after surgery. | Sci Rep | 2025 | https://conductscience.org/library/papers/41107444 | PubMed |
| 41024880 | Re-evaluating surgical strategies in Barcelona Clinic Liver Cancer-B hepatocellular carcinoma. | World J Hepatol | 2025 | https://conductscience.org/library/papers/41024880 | PubMed |
| 41018076 | A comparative study of postural fixation techniques for radiotherapy in upper abdominal malignancies. | Front Oncol | 2025 | https://conductscience.org/library/papers/41018076 | PubMed |
| 40904655 | Interplay of PNPLA3 and TM6SF2 variants in modulating the risk of hepatocellular carcinoma among Egyptian hepatitis C patients. | Clin Exp Hepatol | 2025 | https://conductscience.org/library/papers/40904655 | PubMed |
| 40790551 | Efficacy of prophylactic dexamethasone in reducing post-embolization syndrome following transcatheter arterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis. | BMC Gastroenterol | 2025 | https://conductscience.org/library/papers/40790551 | PubMed |
| 40636794 | Multi-feature weight factor extraction and survival risk assessment of hepatocellular carcinoma based on a clinical missing dataset-independent support vector machine. | ILIVER | 2022 | https://conductscience.org/library/papers/40636794 | PubMed |
| 40512454 | Stereotactic body radiation therapy (SBRT) increases anti-PD-1 antitumor activity by enhancing the tumor immune microenvironment in mice with metastatic hepatocellular carcinoma. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40512454 | PubMed |
| 40380811 | Liver transplantation as a treatment for cancer: comprehensive review. | BJS Open | 2025 | https://conductscience.org/library/papers/40380811 | PubMed |
| 40380115 | RALOX-HAIC (raltitrexed + oxaliplatin) combined with lenvatinib improves survival and safety in elderly patients with unresectable hepatocellular carcinoma. | BMC Cancer | 2025 | https://conductscience.org/library/papers/40380115 | PubMed |
| 40361344 | Extrahepatic Recurrence After Surgical Resection of Hepatocellular Carcinoma Without Intrahepatic Recurrence: A Multi-Institutional Observational Study. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40361344 | PubMed |
| 40361115 | Preoperative plasma cell-free DNA chromosomal instability predicts microvascular invasion in hepatocellular carcinoma: a prospective study. | BMC Cancer | 2025 | https://conductscience.org/library/papers/40361115 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20175034
GET https://conductscience.org/api/papers/v1/20175034/cited_by?page=2